Lessons 4-7 Flashcards

Concepts introduced in lectures/ journal clubs 4-7

You may prefer our related Brainscape-certified flashcards:
1
Q

Mouse Models

A
  • Infant mice have immature immune systems
  • Irradiated mice are immunocompromised because their immune cells have been destroyed
  • Nude mice are genetically defective in the ability to produce T cells
  • Severe combined immunodeficiency (SCID) mice are genetically defective in the ability to produce functional B cells and T cells. Good for studying innate immunity
  • Transgenic mice are genetically defective for example in specific immune cells or immunity genes - often more susceptible to infection
  • Gnotobiotic (germ-free) animals are raised in a germ-free environment. Because of the absence of resident microbiota, they have severely underdeveloped mucosa-associated lymphoid tissues (MALT).
  • Specific-pathogen-free (SPF) animals are raise in an environment free of particular pathogens but are exposed to other microbes (including potential pathogens). Naive against particular pathogen, ensure experimental exposure is primary exposure.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ID of VF: Biochemical Approach

A

Purify virulence factor, and use it to reproduce symptoms associated with infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ID of VF: Molecular Genetic Approach

A

Clone virulence factor gene into avirulent strain -> demonstrate acquired virulence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ID of VF: Transposon mutagenesis

A

Introduce transposon with selectable marker into pathogen to generate collection of mutants. Use marker to see which mutated genes result in loss of virulence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ID of VF: Reporter Fusions

A

Reporter gene expressed only when vf would be. See if coincides with virulence.

  • β-Galactosidase converts X-Gal to deep blue dye. X-Gal supplied through media/agar.
  • GFP - conjugated double bonds
  • Luciferase - bacterial operon produces substrate.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ID of VF: Signature Tagged Mutagenesis

A

Same as transposon mutagenesis, but is used to find genes that are expressed in vivo. A library of barcoded transposon-mutated mutants is created, where one copy of the library is passed through the model (mouse). The control copy and the model-processed copies are compared on micro-arrays containing probes to see which mutants did not survive in host.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ID of VF: In vivo expression technology

A
  • Not very specific, many genes that are detected are housekeeping genes.
  • Bacterial genomic DNA digested, fragment containing desired promoter (Is this directed?) integrated into plasmid containing purA lacZY cassette. Homology-directed recombination leads to the integration of the cassette into the genome, and the doubling of the promoter, so that the cassette is expressed when the promoter’s natural downstream genes are. purA allows the ΔpurA bacterium to survive in the host. Extraction from the host and plating on GalX medium, allows to see which genes are still active outside the host. Theoretically looking for clones that do not turn blue (i.e. gene expressed only in host).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ID of VF: Genomic Subtractive Hybridization

A
  • Id genes present in virulent but not avirulent strains.
  • DNA from both strains digested hybridized, but avirulent strain fragments labeled with biotin and purified with streptavidin. Remaining fragments only in virulent strain.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ID of VF: Selective capture of transcribed sequences

A

mRNA from experimental condition -> cDNA. Hybridized to gDNA, which is bound to biotin and captured with streptavidin. Allows the easy isolation of expressed sequences from a particular organism and separation from other genomes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ID of VF: In-vivo induced antigen technology

A
  • Isolate antibodies from pooled patient (i.e. multiple) serum and present to in-vitro grown bacteria. Label remaining free antibodies and see which ones bind in-vivo grown bacteria.
  • Advantage: Patient serum is readily available, can detect response differences between strains, chronic or acute infections, reduced variability from pooled serum.
  • Limitations: Does not detect cellular immune responses. Construction of genomic expression library in E. coli may lead to variable expression resulting from codon bias, restriction site limitations.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ID of VF: microarray technology

A

Uses chips that contain DNA oligonucleotides corresponding to all genes in the genome. Identifies differences in relative transcript amounts between experimental conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Competitive Index

A

The ratio of fitness between two strains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Trans vs. Cis complementation

A

Trans-complementation means complementing an allele on a plasmid (transient), whereas cis complementation integrates that allele into the genomic DNA.

Complementing allows to confirm the causal nature of a gene-phenotype relationship.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Francisella tularensis

A
  • Very highly infectious bacterium (ID about 10 bacteria). Multiple routes of infection, natural reservoir in rodents. Non-motile, gram -
  • Facultative intracellular pathogen, infects macrophages

Journal Club:
- encounters a bottleneck for systemic spread after s.c. infection, had to inject i.p. Negatively selected genes: capsule, some stress response genes. Some mutants are hypercytotoxic, some v.f.’s suppress macrophage death by limiting the secretion of inflammatory cytokines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Early symptoms of viral infection and their causes

A
  • malaise (tnf-α)
  • fever (IL-1)
  • fatigue

Remember: viral disease = sum of cytopathic effects of virus + tissue damage from host’s anti-viral immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Possible mechanisms of measles-induced immunosuppression

A
  • lymphocyte apoptosis
  • impair lymphocyte proliferative responses
  • induction of immune-suppressive cytokines (IL-4, IL-10)
  • down-regulation of IL-12, preventing differentiation on T cells.
  • impair differentiation and antigen presentation by dendritic cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Respiratory Syncytial virus

A
  • distributed globally
  • causes yearly outbreaks
  • is common in young infants
  • is highly contagious
  • wide range of symptoms. common cold -> life threatening lower respiratory infection (pneumonia) in infants, 70% mortality in infants with congenital heart defect
  • transmitted by aerosol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Immunosuppressive viruses

A
  • measles virus
  • HIV
  • pox virus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

myeloid cells

A

Cells from common myeloid progenitor. Includes monocytes, macrophages, dendritic cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Picornaviruses

A
  • small RNA viruses with + strand genome
  • includes Rhinoviruses (common cold) and enteroviruses (poliovirus, etc…), and hepatitis A
  • common cold escapes immunity by having a huge diversity of serotypes through recombination (template switching during replication) - highly variable capsid proteins.
  • Important aspects of life cycle: Viral RNA translated directly into polyprotein precursor
21
Q

Rotaviruses

A
  • most important cause of severe diarrhea in children
  • dsDNA, complex structure, with 3 protein layers, contains genome, viral RNA polymerases and capping enzyme.
  • Complex life cycle:
    - Endocytosis, txn of genes to help virus move from viroplasm to ER
    - Replication intermediate formation in viroplasm
    - Entry into ER of double-layered particle
    - Golgi-independent vesicular transport or cell lysis
  • endemic throughout globe, highly infectious, fecal-oral spread.
  • frequent watery, dark green, explosive diarrhea.
  • nausea, vomiting, abdominal cramping. No cure, most recover with proper rehydration.
  • preventable (safe and effective vaccine)
22
Q

Paramyxoviruses

A
  • includes measles, mumps, and respiratory syncytial virus

- - strand genome -> translation

23
Q

Mumps

A
  • Childhood disease, but symptoms are more severe later in childhood.
  • Parotitis, myalgia, low fever.
  • Virus replicates in respiratory and GI tract -> lymphoid tissues.
  • Rarely infects CNS, but can lead to deafness, encephalitis, or meningitis
24
Q

Measles

A
  • sporadic outbreaks due to insufficient vaccine coverage
  • only one serotype, no animal reservoir, spread by aerosol
  • characteristic symptom: Koplik’s spots
  • SLAMF1 to enter immune cells which sample lung lumen, Nectin 4 to enter basal membrane of epithelial cells.
  • Persistent measles virus in CNS (intercellular spread through synapses) leads to subacute sclerosing panencephalitis, gradual cognitive and motor decline
  • immunosuppression for 6 months, secondary infection main cause of death.
  • Cell-to-cell transmission in body, myeloid cell pseudopods allow virus to get close to nectin 4 receptor.

Journal Club: Used primary cultures of HAE, MDMs or DCs. HAE grown on small pore, large pore membranes.

25
Q

Hepatitis A

A
  • Acute, no chronic disease, from contaminated food, water

- picornavirus

26
Q

Hepatitis B

A
  • 2B people have been infected world-wide, 2% population chronic infection
  • Most adults asymptomatic, but most children will develop chronic infection as there is no potent IgG response
  • transmitted through blood and infected bodily fluids
  • Chronic infection increases risk to develop liver cancer
  • Only 0.01% of particles infectious, incomplete particles have only HB surface antigen, “decoys”
  • closed circular cDNA can persist in nucleus of infected cells
27
Q

Hepatitis C

A
  • Major cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma
  • 50-80% chronic infection
  • 1 % of Western European pop
  • no vaccine, limited therapeutic options
  • Non-structural proteins curve cell membrane to form “membranous web” - vesicles with replicative machinery.
  • blocks induction of Type I IFNs
  • liver injury corresponds with entry of virus-specific CD8+ (killer) T cells into the liver.
28
Q

Sofosbuvir

A

Anti-HCV prodrug. Blocks NS5B which is the viral RNA polymerase. Causes steric clash with NTPs.

Can cure

29
Q

Emerging Diseases

A

Emerging diseases are zoonotic diseases that crossover. For most important emerging diseases, there is an animal reservoir (bats, rodents), and an insect transmission host

30
Q

Zika

A
  • Flavivirus, + strand encoding polyprotein
  • closely related to Dengue - antibodies are cross-reactive, and allowed Zika cases to hide under Dengue epidemic
  • broad tropism, 80% asymptomatic
  • sexual, vertical, mosquito transmission
  • Originally thought to only cause mild febrile symptoms (severe symptoms are rare, and few patients had disease)
  • Guillain-Barré syndrome
  • microcephaly, other severe brain abnormalities
  • Calcifications, damaged neurons, diffuse activation of astrocytes in fetal brain
  • spontaneous abortion
31
Q

25HC & ZIKV paper

A
  • Product of CH25HC, inhibits ZIKV entry into cell, inhibits infection from other flaviviruses.
  • CH25HC is a product of Type I Interferon stimulated genes.
  • attenuates ZIKV-associated viremia and disease in mouse, non-human primates
  • Prevents ZIKV infection of cortical organoids
  • protects fetal mice from microcephaly cause by ZIKV

NS5 —-| STAT2 —> Txn of IFN pathway genes —-| block v. replication
NS4 A/B —-| mTOR pathway —–| block v. replication

Mice not a natural model for ZIKV: use very high titers to bypass innate immune system in peripheral organs, or use Ifnar1, Ifngr1 knockouts (no IFNα/β, γ)

32
Q

Brain Organoids

A

Recapitulate brain development at an early stage, contain many different cell types and model important cell-cell contact-dependent developmental stage in the brain.

But no immune system

33
Q

Pan-genome

A

Core genome (in all strains) + dispensable genome (strain-specific)

Core genome tends to have genes for central activities like key metabolic pathways, DNA replication, protein Translation

Dispensable genome: pathogenicity, resistance, symbiosis

Open: # of genes increases with # of strains sequenced, typical of species that live in multiple environments.

Closed: # of genes does not increase with # of strains sequenced, typical of species living in isolated niches, with limited access to global microbial gene pool.

34
Q

Prophage

A

Bacteriophage genome integrated into host chromosome. Can reactivate to become lytic.

35
Q

Pathogenicity islands

A

section of genome present only in pathogenic variants containing multiple virulence genes. Often flanked by plasmid or phage genes and are transferred as block during horizontal gene transfer.

Example: Vibrio pathogenicity island coding for Toxin-coregulated pilus.

36
Q

Genome Decay

A

Genome reduction is an evolutionary force often resulting from environmental isolation or endosymbiosis, and leads to loss of metabolic, regulatory, or environmental versatility

Example: Buchner aphidicola - Aphid endosymbiont having lost 75% of ancestral genome.

37
Q

Conjugation

A
  • Method of HGT
  • Bacterial sex
  • Type IV secretion system = sex pilus
  • pilus proteins encoded on F+ plasmid which is copied and transferred during “mating”
38
Q

Integrating Conjugative Element

A
  • Mediator of HGT
  • Self-transmissible mobile genetic elements, plasmid and phage-like features.
  • transfer via conjugation (no pilus)
  • unlike plasmids, do not replicate autonomously.
39
Q

Transduction

A
  • bacteriophage infects cell, and sometimes co-packs bacterial DNA which is then transferred to next target.
40
Q

Natural Competence

A
  • HGT through uptake of free DNA provenant from lysed cells in the environment
  • Remember R (no capsule, avirulent) and S strain (capsule, virulent) experiment
41
Q

CRISPR

A
  • bacterial and archaic defense mechanism against invading DNA
  • clustered regularly interspaced short palindromic repeats
  • bacterial DNA protected from Cas9 and restriction enzymes through methylation
42
Q

E. coli pathotypes

A
  • ETEC: enterotoxigenic ec
  • EPEC: enteropathogenic ec
  • UPEC: uropathogenic ec
  • EHEC: enterohemorrhagic ec
  • EIEC: enteroinvasive ec
43
Q

Pathogenic evolution: E. coli

A
  • normally commensal, facultative anaerobe maintains anaerobiosis in gut. Different strains only share 39% core genome.

German outbreak:

  • E. coli acquire high pathogenicity island, Shigella genes, including Shiga toxin 2
  • Was so deadly because of enhanced adhesion, survival fitness, Stx2 production, and antibiotic resistance (β-lactamase).
  • Caused by contaminated sprouts.
  • Frequently led to hemolytic ureic syndrome
44
Q

Sanger sequencing

A

DNA primers are elongated with DNA template using PCR with a low concentration of labelled ddNTPs, which interrupt elongation, and are integrated at different points stochastically. Capillary electrophoresis allows the separation of DNA fragments by length and thus the deduction of the DNA sequence

45
Q

Illumina sequencing

A

Fragment amplification through bending bridge PCR. Fluorescently labelled nucleotides have a blocking group which is removed by laser during reading of fluorescence. Iterative extension and reading.

46
Q

Pyrosequencing

A

Beads with ssDNA added to well with smaller beads for pyrophosphate reaction. A particular base is added, and if extension occurs, a pyrophosphate group is liberated, which is converted by sulfurylase into ATP. ATP + luciferase -> light

47
Q

Optical mapping

A
  • Used to accelerate whole genome assembly.

- gDNA is digested and stained, indicates the size of the gap between two restriction sites. (fragment size)

48
Q

Non-structural targets of novel HCV drugs

A
  • NS5A Traffics RNA to polymerase, part of “membranous web”

- NS5B - polymerase

49
Q

Some viruses that can affect the nervous system

A
  • ZIKV
  • Herpes Simplex
  • West-nile
  • poliovirus
  • Rabies virus